Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
9,017,002
-
Share change
-
+3,609,761
-
Total reported value
-
$9,558,000
-
Put/Call ratio
-
0%
-
Price per share
-
$1.06
-
Number of holders
-
18
-
Value change
-
+$3,817,525
-
Number of buys
-
7
-
Number of sells
-
7
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q1 2022
As of 31 Mar 2022,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,017,002 shares.
The largest 10 holders included
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, STONEHILL CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, Whitefort Capital Management, LP, MORGAN STANLEY, LPL Financial LLC, ENVESTNET ASSET MANAGEMENT INC, and MILLENNIUM MANAGEMENT LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.